These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 31456384)
21. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. Arslan H; Azap OK; Ergönül O; Timurkaynak F; J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685 [TBL] [Abstract][Full Text] [Related]
22. Escherichia coli antimicrobial resistance increased faster among geriatric outpatients compared with adult outpatients in the USA, 2000-10. Sanchez GV; Adams SJ; Baird AM; Master RN; Clark RB; Bordon JM J Antimicrob Chemother; 2013 Aug; 68(8):1838-41. PubMed ID: 23557923 [TBL] [Abstract][Full Text] [Related]
23. Antimicrobial Resistance Pattern and Genetic Characteristics of ESBL and Carbapenemase-producing Escherichia coli at a Tertiary Care Hospital in Bangladesh. Khan ER; Paul SK; Kobayashi N; Khan TR; Rahman MH; Rahman MM Mymensingh Med J; 2020 Jan; 29(1):37-42. PubMed ID: 31915333 [TBL] [Abstract][Full Text] [Related]
24. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program. Al Rahmany D; Albeloushi A; Alreesi I; Alzaabi A; Alreesi M; Pontiggia L; Ghazi IM Int J Infect Dis; 2019 Jun; 83():77-82. PubMed ID: 30959249 [TBL] [Abstract][Full Text] [Related]
25. Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to Ciprofloxacin. O'Brien KA; Zhang J; Mauldin PD; Gomez J; Hurst JM; Sean Boger M; Bosso JA Pharmacotherapy; 2015 May; 35(5):464-9. PubMed ID: 26011139 [TBL] [Abstract][Full Text] [Related]
26. Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study. Nagarjuna D; Mittal G; Dhanda RS; Gaind R; Yadav M Antimicrob Resist Infect Control; 2018; 7():150. PubMed ID: 30555689 [TBL] [Abstract][Full Text] [Related]
27. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441 [TBL] [Abstract][Full Text] [Related]
28. Antibiotic stewardship: ripartiamo dalla pratica clinica. Tascini C Urologia; 2018 Jul; 85(1_suppl):S20-S23. PubMed ID: 30081776 [TBL] [Abstract][Full Text] [Related]
29. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Caron F; Etienne M Am J Med; 2010 Mar; 123(3):e13. PubMed ID: 20193811 [No Abstract] [Full Text] [Related]
30. Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis. Abelson Storby K; Osterlund A; Kahlmeter G Acta Paediatr; 2004 Apr; 93(4):487-91. PubMed ID: 15188976 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Williams DN; Sannes MR; Eckhoff AA; Peterson PK; Johnson JR; Sannes MR; San Román M; Mora N; Moya J Int J Antimicrob Agents; 2003 Jan; 21(1):79-81. PubMed ID: 12507843 [No Abstract] [Full Text] [Related]
32. Urinary Escherichia coli antimicrobial susceptibility profiles and their relationship with community antibiotic use in Tasmania, Australia. Meumann EM; Mitchell BG; McGregor A; McBryde E; Cooley L Int J Antimicrob Agents; 2015 Oct; 46(4):389-93. PubMed ID: 26187365 [TBL] [Abstract][Full Text] [Related]
33. Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection. Tchesnokova V; Avagyan H; Rechkina E; Chan D; Muradova M; Haile HG; Radey M; Weissman S; Riddell K; Scholes D; Johnson JR; Sokurenko EV PLoS One; 2017; 12(3):e0174132. PubMed ID: 28350870 [TBL] [Abstract][Full Text] [Related]
34. Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates: 12-year ecological study using a nationwide surveillance and antimicrobial prescription database. Kim YA; Park YS; Youk T; Lee H; Lee K PLoS One; 2018; 13(12):e0209580. PubMed ID: 30596704 [TBL] [Abstract][Full Text] [Related]
35. Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study. Hernandez-Santiago V; Davey PG; Nathwani D; Marwick CA; Guthrie B PLoS Med; 2019 Jun; 16(6):e1002825. PubMed ID: 31173597 [TBL] [Abstract][Full Text] [Related]
36. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia. Yeshitela B; Gebre-Selassie S; Feleke Y Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407 [TBL] [Abstract][Full Text] [Related]
37. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul]. Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421 [TBL] [Abstract][Full Text] [Related]
38. Emergence of mcr-1 and mcr-3 variants coding for plasmid-mediated colistin resistance in Escherichia coli isolates from food- producing animals in South Korea. Belaynehe KM; Shin SW; Park KY; Jang JY; Won HG; Yoon IJ; Yoo HS Int J Infect Dis; 2018 Jul; 72():22-24. PubMed ID: 29803875 [TBL] [Abstract][Full Text] [Related]
39. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil. Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868 [TBL] [Abstract][Full Text] [Related]
40. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. Moremi N; Claus H; Mshana SE BMC Infect Dis; 2016 Dec; 16(1):756. PubMed ID: 27964724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]